rss
Sex Transm Infect 2006;82:269-271 doi:10.1136/sti.2005.017368
  • Reviews

Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment

  1. J D C Ross1,
  2. J S Jensen2
  1. 1Whittall Street Clinic, Birmingham B4 6DH, UK
  2. 2Statens Serum Institut, Artillerivej 5, DK-2300 Copenhagen S, Denmark
  1. Correspondence to:
 Professor J Ross
 Whittall Street Clinic, Whittall Street, Birmingham B4 6DH, UK; jonathan.ross{at}hobtpct.nhs.uk
  • Accepted 23 March 2006

Abstract

The evidence that Mycoplasma genitalium is a sexually transmitted pathogen is virtually incontrovertible based on both the concordance rates among partners and on DNA typing showing the same sequence type among partners in contrast to unrelated M genitalium positive patients. The implications that this has for the screening, testing, and treatment of patients is less certain however. Which tests are the most sensitive and specific, what samples are most appropriate, who should be tested, what treatment is best and how should partners be managed?

Footnotes

  • JR and JJ jointly wrote and revised the manuscript.

  • Declaration of interests: JR has received consultancy fees from Bayer and Pfizer and is an associate editor of Sexually Transmitted Infections.

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.